| 1 | Hypochromic microcytic anemia | Direct | | |
| 2 | Breast cancer | Enrichment | AKT1, APC, JUN, PIK3CA, PTEN, TP53 | 6.46 |
| 3 | Hereditary breast carcinoma | Enrichment | AKT1, APC, PIK3CA, PTEN, TP53 | 6.22 |
| 4 | Breast adenocarcinoma | Enrichment | AKT1, PIK3CA, TP53 | 6.00 |
| 5 | Cowden syndrome | Enrichment | AKT1, PIK3CA, PTEN | 5.38 |
| 6 | Meningioma | Enrichment | AKT1, PIK3CA, PTEN | 4.97 |
| 7 | Colorectal cancer | Enrichment | AKT1, APC, CCND1, PIK3CA, TP53 | 4.74 |
| 8 | Gastric cancer | Enrichment | APC, PIK3CA, PTEN, TP53 | 4.71 |
| 9 | Ovarian cancer | Enrichment | AKT1, APC, PIK3CA, PTEN, TP53 | 4.43 |
| 10 | Diffuse large b-cell lymphoma | Enrichment | FOXO1, PTEN, TP53 | 4.33 |
| 11 | Hepatocellular carcinoma | Enrichment | APC, PIK3CA, TP53 | 4.13 |
| 12 | Rhabdomyosarcoma 2 | Enrichment | FOXO1, TP53 | 3.86 |
| 13 | Acute megakaryocytic leukemia | Enrichment | PTEN, TP53 | 3.86 |
| 14 | Hemimegalencephaly | Enrichment | PIK3CA, PTEN | 3.86 |
| 15 | Bladder cancer | Enrichment | PIK3CA, PTEN, TP53 | 3.77 |
| 16 | Prostate cancer | Enrichment | PIK3CA, PTEN, TP53 | 3.77 |
| 17 | Li-fraumeni syndrome | Enrichment | MDM2, TP53 | 3.69 |
| 18 | Cowden syndrome 1 | Enrichment | PIK3CA, PTEN | 3.69 |
| 19 | Squamous cell carcinoma, head and neck | Enrichment | PTEN, TP53 | 3.54 |
| 20 | Gallbladder cancer | Enrichment | PIK3CA, TP53 | 3.54 |
| 21 | Wolff syndrome | Enrichment | ATP7B | 3.53 |
| 22 | Neuronopathy, distal hereditary motor, x-linked | Enrichment | ATP7A | 3.53 |
| 23 | Anemia, hypochromic microcytic, with iron overload 1 | Enrichment | SLC11A2 | 3.53 |
| 24 | Neurodegeneration and seizures due to copper transport defect | Enrichment | SLC31A1 | 3.53 |
| 25 | Occipital horn syndrome | Enrichment | ATP7A | 3.53 |
| 26 | Intellectual disability, wolff type | Enrichment | ATP7B | 3.53 |
| 27 | Adult hepatocellular carcinoma | Enrichment | PIK3CA, TP53 | 3.31 |
| 28 | Developmental and epileptic encephalopathy 93 | Enrichment | ATP7B | 3.23 |
| 29 | Deafness, autosomal recessive 109 | Enrichment | ATP7B | 3.23 |
| 30 | Leukemia, chronic lymphocytic | Enrichment | CCND1, TP53 | 3.21 |
| 31 | Wilson disease | Enrichment | ATP7B | 3.05 |
| 32 | Menkes disease | Enrichment | ATP7A | 3.05 |
| 33 | Breast-ovarian cancer, familial 5 | Enrichment | ATP7B | 3.05 |
| 34 | Lip and oral cavity carcinoma | Enrichment | PIK3CA, TP53 | 3.05 |
| 35 | Alzheimer's disease | Enrichment | APP, MAPT | 2.98 |
| 36 | Rhabdomyosarcoma | Enrichment | PTEN, TP53 | 2.79 |
| 37 | Alzheimer disease, familial, 1 | Enrichment | APP, MAPT | 2.74 |
| 38 | Endometrial cancer | Enrichment | PIK3CA, PTEN | 2.56 |
| 39 | Hepatoblastoma | Enrichment | APC, TP53 | 2.56 |
| 40 | Macrodactyly | Enrichment | PIK3CA | 2.42 |
| 41 | Proteus syndrome | Enrichment | AKT1 | 2.42 |
| 42 | Vacterl association with hydrocephalus | Enrichment | PTEN | 2.42 |
| 43 | Fatal familial insomnia | Enrichment | PRNP | 2.42 |
| 44 | Lymphoproliferative syndrome, x-linked, 2 | Enrichment | XIAP | 2.42 |
| 45 | Cone-rod dystrophy 9 | Enrichment | ADAM9 | 2.42 |
| 46 | Megalencephaly, autosomal dominant | Enrichment | PIK3CA | 2.42 |
| 47 | Gerstmann-straussler disease | Enrichment | PRNP | 2.42 |
| 48 | Cowden syndrome 5 | Enrichment | PIK3CA | 2.42 |
| 49 | Kuru | Enrichment | PRNP | 2.42 |
| 50 | Accelerated tumor formation | Enrichment | MDM2 | 2.42 |
| 51 | Cerebral cavernous malformations 4 | Enrichment | PIK3CA | 2.42 |
| 52 | Lessel-kubisch syndrome | Enrichment | MDM2 | 2.42 |
| 53 | Bone marrow failure syndrome 5 | Enrichment | TP53 | 2.42 |
| 54 | Mitochondrial complex iv deficiency, nuclear type 23 | Enrichment | COX11 | 2.42 |
| 55 | Spongiform encephalopathy with neuropsychiatric features | Enrichment | PRNP | 2.42 |
| 56 | Papilloma of choroid plexus | Enrichment | TP53 | 2.42 |
| 57 | Parkinson-dementia syndrome | Enrichment | MAPT | 2.42 |
| 58 | Basal cell carcinoma 7 | Enrichment | TP53 | 2.42 |
| 59 | Anaplastic thyroid carcinoma | Enrichment | TP53 | 2.42 |
| 60 | Supranuclear palsy, progressive, 1 | Enrichment | MAPT | 2.42 |
| 61 | Huntington disease-like 1 | Enrichment | PRNP | 2.42 |
| 62 | Papillary tumor of the pineal region | Enrichment | PTEN | 2.42 |
| 63 | Alzheimer disease 18 | Enrichment | ADAM10 | 2.42 |
| 64 | Progressive supranuclear palsy | Enrichment | MAPT | 2.42 |
| 65 | Hemifacial myohyperplasia | Enrichment | PIK3CA | 2.42 |
| 66 | Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth | Enrichment | PIK3CA | 2.42 |
| 67 | Cerebral amyloid angiopathy, app-related | Enrichment | APP | 2.42 |
| 68 | Familial alzheimer-like prion disease | Enrichment | PRNP | 2.42 |
| 69 | Cowden syndrome 6 | Enrichment | AKT1 | 2.42 |
| 70 | Reticulate acropigmentation of kitamura | Enrichment | ADAM10 | 2.42 |
| 71 | Glioma susceptibility 2 | Enrichment | PTEN | 2.42 |
| 72 | Ductal carcinoma in situ | Enrichment | TP53 | 2.42 |
| 73 | Prion disease | Enrichment | PRNP | 2.42 |
| 74 | Classic progressive supranuclear palsy syndrome | Enrichment | MAPT | 2.42 |
| 75 | Segmental progressive overgrowth syndrome with fibroadipose hyperplasia | Enrichment | PIK3CA | 2.42 |
| 76 | Thyroid gland undifferentiated carcinoma | Enrichment | TP53 | 2.42 |
| 77 | Small-cell carcinoma of the ovary of hypercalcemic type | Enrichment | TP53 | 2.42 |
| 78 | Atypical progressive supranuclear palsy syndrome | Enrichment | MAPT | 2.42 |
| 79 | Hypospadias | Enrichment | PIK3CA | 2.42 |
| 80 | Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype | Enrichment | TP53 | 2.42 |
| 81 | Choroid plexus cancer | Enrichment | TP53 | 2.42 |
| 82 | Rare venous malformation | Enrichment | PIK3CA | 2.42 |
| 83 | Prp systemic amyloidosis | Enrichment | PRNP | 2.42 |
| 84 | Familial adenomatous polyposis | Enrichment | APC | 2.42 |
| 85 | Diaphragmatic eventration | Enrichment | PIK3CA | 2.42 |
| 86 | Pik3ca-related overgrowth spectrum | Enrichment | PIK3CA | 2.42 |
| 87 | Inherited human prion disease | Enrichment | PRNP | 2.42 |
| 88 | Pleomorphic xanthoastrocytoma | Enrichment | TP53 | 2.42 |
| 89 | Rare combined vascular malformation | Enrichment | PIK3CA | 2.42 |
| 90 | Cavernous lymphangioma | Enrichment | PIK3CA | 2.42 |
| 91 | Pik3ca-related overgrowth syndrome | Enrichment | PIK3CA | 2.42 |
| 92 | Gardner syndrome | Enrichment | APC | 2.42 |
| 93 | 5q22 microdeletion syndrome | Enrichment | APC | 2.42 |
| 94 | Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome | Enrichment | PTEN | 2.42 |
| 95 | Attenuated familial adenomatous polyposis | Enrichment | APC | 2.42 |
| 96 | Hemihyperplasia-multiple lipomatosis syndrome | Enrichment | PIK3CA | 2.42 |
| 97 | Eccrine angiomatous hamartoma | Enrichment | PIK3CA | 2.42 |
| 98 | Macrodactyly of toe | Enrichment | PIK3CA | 2.42 |
| 99 | Inherited creutzfeldt-jakob disease | Enrichment | PRNP | 2.42 |
| 100 | Cerebral amyloid angiopathy, cst3-related | Enrichment | APP | 2.12 |
| 101 | Adrenocortical carcinoma, hereditary | Enrichment | TP53 | 2.12 |
| 102 | Cervical cancer | Enrichment | TP53 | 2.12 |
| 103 | Pick disease of brain | Enrichment | MAPT | 2.12 |
| 104 | Keratosis, seborrheic | Enrichment | PIK3CA | 2.12 |
| 105 | Creutzfeldt-jakob disease | Enrichment | PRNP | 2.12 |
| 106 | Anemia, hypochromic microcytic, with iron overload 2 | Enrichment | STEAP3 | 2.12 |
| 107 | Noonan syndrome 8 | Enrichment | PIK3CA | 2.12 |
| 108 | Lymphoma, hodgkin, classic | Enrichment | TP53 | 2.12 |
| 109 | Rosette-forming glioneuronal tumor | Enrichment | PIK3CA | 2.12 |
| 110 | Congenital fibrosarcoma | Enrichment | TP53 | 2.12 |
| 111 | Li-fraumeni syndrome 1 | Enrichment | TP53 | 2.12 |
| 112 | Sarcoma | Enrichment | TP53 | 2.12 |
| 113 | Inflammatory skin and bowel disease, neonatal, 1 | Enrichment | ADAM17 | 2.12 |
| 114 | Spastic tetraplegia and axial hypotonia, progressive | Enrichment | SOD1 | 2.12 |
| 115 | Periampullary adenoma | Enrichment | APC | 2.12 |
| 116 | Gastric adenocarcinoma and proximal polyposis of the stomach | Enrichment | APC | 2.12 |
| 117 | Cervix carcinoma | Enrichment | TP53 | 2.12 |
| 118 | Hodgkin's lymphoma | Enrichment | TP53 | 2.12 |
| 119 | Mitochondrial complex iv deficiency, nuclear type 4 | Enrichment | SCO1 | 2.12 |
| 120 | Vacterl with hydrocephalus | Enrichment | PTEN | 2.12 |
| 121 | Juvenile polyposis of infancy | Enrichment | PTEN | 2.12 |
| 122 | Pleomorphic rhabdomyosarcoma | Enrichment | TP53 | 2.12 |
| 123 | Hirschsprung disease 1 | Enrichment | ATP7A | 2.07 |
| 124 | Desmoid disease, hereditary | Enrichment | APC | 1.95 |
| 125 | Pompe disease, infantile-onset | Enrichment | PIK3CA | 1.95 |
| 126 | Osteogenic sarcoma | Enrichment | TP53 | 1.95 |
| 127 | Nasopharyngeal carcinoma | Enrichment | TP53 | 1.95 |
| 128 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | PIK3CA | 1.95 |
| 129 | Cenani-lenz syndactyly syndrome | Enrichment | APC | 1.95 |
| 130 | Desmoid tumor | Enrichment | APC | 1.95 |
| 131 | Dedifferentiated liposarcoma | Enrichment | MDM2 | 1.95 |
| 132 | Atypical teratoid rhabdoid tumor | Enrichment | TP53 | 1.95 |
| 133 | Anaplastic astrocytoma | Enrichment | TP53 | 1.95 |
| 134 | Squamous cell carcinoma | Enrichment | TP53 | 1.95 |
| 135 | Adenocarcinoma | Enrichment | TP53 | 1.95 |
| 136 | Laryngeal squamous cell carcinoma | Enrichment | PTEN | 1.95 |
| 137 | Bone osteosarcoma | Enrichment | TP53 | 1.95 |
| 138 | Colon adenocarcinoma | Enrichment | APC | 1.95 |
| 139 | Neonatal inflammatory skin and bowel disease | Enrichment | ADAM17 | 1.95 |
| 140 | Well-differentiated liposarcoma | Enrichment | MDM2 | 1.95 |
| 141 | Keratoacanthoma | Enrichment | PIK3CA | 1.95 |
| 142 | Apc-associated polyposis conditions | Enrichment | APC | 1.95 |
| 143 | Inherited cancer-predisposing syndrome | Enrichment | APC, PTEN, TP53 | 1.87 |
| 144 | Dowling-degos disease 1 | Enrichment | ADAM10 | 1.83 |
| 145 | Small cell cancer of the lung | Enrichment | TP53 | 1.83 |
| 146 | Thyroid cancer, nonmedullary, 1 | Enrichment | TP53 | 1.83 |
| 147 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | PIK3CA | 1.83 |
| 148 | Frontotemporal dementia 2 | Enrichment | PRNP | 1.83 |
| 149 | Lymphoproliferative syndrome 2 | Enrichment | XIAP | 1.83 |
| 150 | Mantle cell lymphoma | Enrichment | CCND1 | 1.83 |
| 151 | Lung sarcomatoid carcinoma | Enrichment | TP53 | 1.83 |
| 152 | Cerebrovascular disease | Enrichment | PIK3CA | 1.83 |
| 153 | Embryonal rhabdomyosarcoma | Enrichment | TP53 | 1.83 |
| 154 | Craniopharyngioma | Enrichment | APC | 1.83 |
| 155 | Familial cerebral cavernous malformations | Enrichment | PIK3CA | 1.83 |
| 156 | Glioma | Enrichment | PTEN | 1.83 |
| 157 | Spastic ataxia | Enrichment | ATP7B | 1.81 |
| 158 | Hereditary breast ovarian cancer syndrome | Enrichment | PTEN, TP53 | 1.74 |
| 159 | Capillary malformations, congenital | Enrichment | PIK3CA | 1.73 |
| 160 | Von hippel-lindau syndrome | Enrichment | CCND1 | 1.73 |
| 161 | Macrocephaly/autism syndrome | Enrichment | PTEN | 1.73 |
| 162 | Amyotrophic lateral sclerosis 10 with or without frontotemporal dementia | Enrichment | SOD1 | 1.73 |
| 163 | Familial adenomatous polyposis 1 | Enrichment | APC | 1.73 |
| 164 | Cox deficiency, infantile mitochondrial myopathy | Enrichment | SCO1 | 1.73 |
| 165 | Lymphoma | Enrichment | TP53 | 1.73 |
| 166 | Hemangioma | Enrichment | PTEN | 1.73 |
| 167 | Dementia | Enrichment | MAPT | 1.73 |
| 168 | Myeloma, multiple | Enrichment | CCND1, TP53 | 1.73 |
| 169 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | MAPT, SOD1 | 1.70 |
| 170 | Klippel-trenaunay-weber syndrome | Enrichment | PIK3CA | 1.65 |
| 171 | Hemihyperplasia, isolated | Enrichment | PIK3CA | 1.65 |
| 172 | Adrenocortical carcinoma | Enrichment | TP53 | 1.65 |
| 173 | Lung squamous cell carcinoma | Enrichment | PIK3CA | 1.65 |
| 174 | Esophageal cancer | Enrichment | TP53 | 1.58 |
| 175 | Nevus, epidermal | Enrichment | PIK3CA | 1.58 |
| 176 | Thyroid cancer, nonmedullary, 2 | Enrichment | PTEN | 1.58 |
| 177 | Capillary malformation-arteriovenous malformation 1 | Enrichment | PIK3CA | 1.58 |
| 178 | Semantic dementia | Enrichment | MAPT | 1.58 |
| 179 | Alzheimer's disease 1 | Enrichment | APP | 1.58 |
| 180 | Essential thrombocythemia | Enrichment | TP53 | 1.58 |
| 181 | Motor neuron disease | Enrichment | SOD1 | 1.58 |
| 182 | Follicular thyroid carcinoma | Enrichment | PTEN | 1.58 |
| 183 | Early-onset autosomal dominant alzheimer disease | Enrichment | APP | 1.58 |
| 184 | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | Enrichment | TP53 | 1.58 |
| 185 | Glioma susceptibility 1 | Enrichment | TP53 | 1.53 |
| 186 | Lymphoma, non-hodgkin, familial | Enrichment | TP53 | 1.53 |
| 187 | Arteriovenous malformation | Enrichment | PIK3CA | 1.48 |
| 188 | Progressive non-fluent aphasia | Enrichment | MAPT | 1.48 |
| 189 | Primary hyperaldosteronism | Enrichment | TP53 | 1.48 |
| 190 | Colonic benign neoplasm | Enrichment | APC | 1.48 |
| 191 | Behavioral variant of frontotemporal dementia | Enrichment | MAPT | 1.48 |
| 192 | Amyotrophic lateral sclerosis 1 | Enrichment | SOD1 | 1.43 |
| 193 | Myopathy, x-linked, with excessive autophagy | Enrichment | PIK3CA | 1.43 |
| 194 | Melanoma | Enrichment | PTEN | 1.43 |
| 195 | Familial colorectal cancer | Enrichment | TP53 | 1.43 |
| 196 | Frontotemporal dementia 1 | Enrichment | MAPT | 1.39 |
| 197 | Meningioma, familial | Enrichment | PTEN | 1.39 |
| 198 | Myelodysplastic syndrome | Enrichment | TP53 | 1.39 |
| 199 | Lung non-small cell carcinoma | Enrichment | PIK3CA | 1.39 |
| 200 | Uterine corpus cancer | Enrichment | PTEN | 1.39 |
| 201 | Medulloblastoma | Enrichment | APC | 1.29 |
| 202 | Lung cancer susceptibility 3 | Enrichment | TP53 | 1.29 |
| 203 | Lynch syndrome | Enrichment | PIK3CA | 1.26 |
| 204 | Gliosarcoma | Enrichment | TP53 | 1.23 |
| 205 | Giant cell glioblastoma | Enrichment | TP53 | 1.21 |
| 206 | Mitochondrial complex iv deficiency, nuclear type 1 | Enrichment | SCO1 | 1.10 |
| 207 | Diamond-blackfan anemia 1 | Enrichment | TP53 | 1.08 |
| 208 | Parkinson disease, late-onset | Enrichment | MAPT | 1.06 |
| 209 | Autoinflammatory disease | Enrichment | XIAP | 1.06 |
| 210 | Pancreatic cancer | Enrichment | TP53 | 1.05 |
| 211 | Lung cancer | Enrichment | PIK3CA | 0.94 |
| 212 | Diamond-blackfan anemia | Enrichment | TP53 | 0.90 |
| 213 | Leukemia, acute myeloid | Enrichment | TP53 | 0.85 |
| 214 | Hypertelorism | Enrichment | PIK3CA | 0.75 |
| 215 | Cone-rod dystrophy 2 | Enrichment | ADAM9 | 0.65 |
| 216 | Congenital nervous system abnormality | Enrichment | PTEN | 0.48 |
| 217 | Nervous system disease | Enrichment | PTEN | 0.48 |
| 218 | Autism spectrum disorder | Enrichment | PTEN | 0.47 |
| 219 | Retinitis pigmentosa | Enrichment | ADAM9 | 0.26 |
| 220 | Hereditary retinal dystrophy | Enrichment | ADAM9 | 0.17 |
| 221 | Fundus dystrophy | Enrichment | ADAM9 | 0.17 |